midodrine hydrochloride

Generic: midodrine hydrochloride

Labeler: apotex corp
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name midodrine hydrochloride
Generic Name midodrine hydrochloride
Labeler apotex corp
Dosage Form TABLET
Routes
ORAL
Active Ingredients

midodrine hydrochloride 2.5 mg/1

Manufacturer
Apotex Corp

Identifiers & Regulatory

Product NDC 60505-1320
Product ID 60505-1320_ef40d4d7-e3ab-70fd-f7a0-b9c02055f734
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077746
Listing Expiration 2026-12-31
Marketing Start 2006-09-12

Pharmacologic Class

Classes
adrenergic alpha-agonists [moa] alpha-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 605051320
Hyphenated Format 60505-1320

Supplemental Identifiers

RxCUI
993462 993466 993470
UNII
59JV96YTXV

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name midodrine hydrochloride (source: ndc)
Generic Name midodrine hydrochloride (source: ndc)
Application Number ANDA077746 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (60505-1320-1)
  • 30 TABLET in 1 BOTTLE (60505-1320-3)
  • 500 TABLET in 1 BOTTLE (60505-1320-5)
  • 1000 TABLET in 1 BOTTLE (60505-1320-8)
source: ndc

Packages (4)

Ingredients (1)

midodrine hydrochloride (2.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ef40d4d7-e3ab-70fd-f7a0-b9c02055f734", "openfda": {"unii": ["59JV96YTXV"], "rxcui": ["993462", "993466", "993470"], "spl_set_id": ["aec0d2de-ce83-b7c2-5d10-740607d50521"], "manufacturer_name": ["Apotex Corp"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (60505-1320-1)", "package_ndc": "60505-1320-1", "marketing_start_date": "20060912"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (60505-1320-3)", "package_ndc": "60505-1320-3", "marketing_start_date": "20060912"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (60505-1320-5)", "package_ndc": "60505-1320-5", "marketing_start_date": "20060912"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (60505-1320-8)", "package_ndc": "60505-1320-8", "marketing_start_date": "20060912"}], "brand_name": "Midodrine Hydrochloride", "product_id": "60505-1320_ef40d4d7-e3ab-70fd-f7a0-b9c02055f734", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "60505-1320", "generic_name": "Midodrine Hydrochloride", "labeler_name": "Apotex Corp", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Midodrine Hydrochloride", "active_ingredients": [{"name": "MIDODRINE HYDROCHLORIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA077746", "marketing_category": "ANDA", "marketing_start_date": "20060912", "listing_expiration_date": "20261231"}